Eiger BioPharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EIGR and other ETFs, options, and stocks.

About EIGR

Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. 

CEO
David A. Cory
CEODavid A. Cory
Employees
43
Employees43
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2008
Founded2008
Employees
43
Employees43

EIGR Key Statistics

Market cap
317.88M
Market cap317.88M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
290.47K
Average volume290.47K
High today
$7.58
High today$7.58
Low today
$7.14
Low today$7.14
Open price
$7.58
Open price$7.58
Volume
159.79K
Volume159.79K
52 Week high
$10.02
52 Week high$10.02
52 Week low
$3.53
52 Week low$3.53

EIGR News

Simply Wall St 5d
Eiger BioPharmaceuticals, Inc. is a favorite amongst institutional investors who own 61% - Yahoo Finance

Every investor in Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) should be aware of the most powerful shareholder groups. We can see that institutions own the lio...

Eiger BioPharmaceuticals, Inc. is a favorite amongst institutional investors who own 61% - Yahoo Finance

EIGR Earnings

-$0.65
-$0.15
$0.35
$0.85
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.